Neptune Wellness Solutions Inc. Stock price Toronto S.E.
Equities
NEPT
CA64079L2049
Pharmaceuticals
Sales 2022 | 48.8M 36.01M | Sales 2023 | 52.62M 38.82M | Capitalization | 6.36M 4.69M |
---|---|---|---|---|---|
Net income 2022 | -75M -55.34M | Net income 2023 | -60M -44.27M | EV / Sales 2022 | 0.97 x |
Net Debt 2022 | 5.61M 4.14M | Net Debt 2023 | 23.3M 17.19M | EV / Sales 2023 | 0.56 x |
P/E ratio 2022 |
-0.5
x | P/E ratio 2023 |
-0.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58% |
1st Jan change | Capi. | |
---|---|---|
+31.40% | 3.95B | |
+144.96% | 2.36B | |
+316.39% | 61.42M | |
+65.08% | 56.01M |